ABR

AMD Instinct MI300X Accelerators Power Microsoft Azure OpenAI Service Workloads and New Azure ND MI300X V5 VMs

Retrieved on: 
tisdag, maj 21, 2024

SANTA CLARA, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Today at Microsoft Build, AMD (NASDAQ: AMD) showcased its latest end-to-end compute and software capabilities for Microsoft customers and developers. By using AMD solutions such as AMD Instinct™ MI300X accelerators, ROCm™ open software, Ryzen™ AI processors and software, and Alveo™ MA35D media accelerators, Microsoft is able to provide a powerful suite of tools for AI-based deployments across numerous markets. The new Microsoft Azure ND MI300X virtual machines (VMs) are now generally available, giving customers like Hugging Face, access to impressive performance and efficiency for their most demanding AI workloads.

Key Points: 
  • The new Microsoft Azure ND MI300X virtual machines (VMs) are now generally available, giving customers like Hugging Face, access to impressive performance and efficiency for their most demanding AI workloads.
  • “The AMD Instinct MI300X and ROCm software stack is powering the Azure OpenAI Chat GPT 3.5 and 4 services, which are some of the world’s most demanding AI workloads,” said Victor Peng, president, AMD.
  • With AMD Instinct MI300X and the proven and ready ROCm open software stack, Microsoft is able to achieve leading price/performance on GPT inference workloads.
  • Microsoft has selected the AMD Alveo™ MA35D media accelerator to power its vast live streaming video workloads, including Microsoft Teams, SharePoint video, and others.

Arbor Realty Trust Points to its Public Disclosures and Strong Performance in Light of Continued Negative Press from Short Interest

Retrieved on: 
onsdag, maj 8, 2024

In light of the current environment and the continued elevated short interest in our company, we anticipate more of these short seller “reports” in the near future, which may also be featured in the press.

Key Points: 
  • In light of the current environment and the continued elevated short interest in our company, we anticipate more of these short seller “reports” in the near future, which may also be featured in the press.
  • Rather than relying on short seller “reports,” or press articles, we encourage everyone to carefully review our comprehensive public statements and disclosures.
  • Our materials detail Arbor's continued success in managing through a very challenging environment and demonstrates our ability to consistently outperform our peers.
  • Please refer to the Investor Materials page of the Investor Relations section of our corporate website for charts on our performance.

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks

Retrieved on: 
onsdag, maj 8, 2024

TARRYTOWN, N.Y., May 08, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11 months of age) within 24 weeks, and initial hearing improvements were observed in a second child (dosed at 4 years of age) at a 6-week assessment. Both children were born with profound genetic deafness due to variants of the otoferlin gene, and the child dosed at 11 months of age is one of the youngest in the world to receive a gene therapy for genetic deafness. The results are from the ongoing Phase 1/2 CHORD trial, which is currently enrolling infants and children and were detailed during an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) annual conference.

Key Points: 
  • The surgical procedure leverages the same approach used for cochlear implants, which is amenable for use in young infants.
  • Hearing improvements were assessed by pure tone audiometry (PTA) and auditory brainstem response (ABR).
  • At baseline, both participants had no behavioral (PTA) or electrophysiological (ABR) responses at maximum sound levels (≥100 dB).
  • The potential use of DB-OTO for otoferlin-related hearing loss is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.

Peakstone Realty Trust Reports First Quarter 2024 Results

Retrieved on: 
tisdag, maj 7, 2024

Peakstone Realty Trust ("PKST" or the "Company") (NYSE: PKST), a real estate investment trust that owns and operates a high-quality, newer-vintage portfolio of predominantly single-tenant industrial and office properties, today announced its financial results for the quarter ended March 31, 2024.

Key Points: 
  • Peakstone Realty Trust ("PKST" or the "Company") (NYSE: PKST), a real estate investment trust that owns and operates a high-quality, newer-vintage portfolio of predominantly single-tenant industrial and office properties, today announced its financial results for the quarter ended March 31, 2024.
  • In the first quarter, total revenue was approximately $59.2 million compared to $67.0 million for the same quarter last year.
  • In the first quarter, Same Store Cash NOI increased 0.7% to approximately $44.8 million compared to $44.5 million for the same quarter last year.
  • PKST will host a webcast to present the first quarter results on Tuesday, May 7, 2024 at 5:00 p.m. Eastern Time.

BROAD STREET REALTY, INC. Update from Michael Z. Jacoby, Chairman of the Board and Chief Executive Officer

Retrieved on: 
måndag, maj 6, 2024

RESTON, Va., May 6, 2024 /PRNewswire/ -- Broad Street Realty, Inc. (OTCQX: BRST)

Key Points: 
  • RESTON, Va., May 6, 2024 /PRNewswire/ -- Broad Street Realty, Inc. (OTCQX: BRST)
    At Broad Street, our vision has always been to strive "to empower people and places".
  • Thankfully, this focus has rewarded us with the ability to weather both the Covid era and an incredibly difficult lending environment.
  • Unfortunately, this was a very accurate statement and as of today, this condition has not changed.
  • Credit is the lifeblood of a capital-intensive business such as that of commercial real estate ownership.

Broadstone Net Lease Announces First Quarter 2024 Results

Retrieved on: 
onsdag, maj 1, 2024

The gross proceeds represented a $2.1 million gain over original purchase price and a $55.5 million net gain over carrying value.

Key Points: 
  • The gross proceeds represented a $2.1 million gain over original purchase price and a $55.5 million net gain over carrying value.
  • As of March 31, 2024, we had total outstanding debt of $1.9 billion, Net Debt of $1.7 billion, a Net Debt to Annualized Adjusted EBITDAre ratio of 4.8x, and a Pro Forma Net Debt to Annualized Adjusted EBITDAre ratio of 4.6x.
  • We did not raise any equity during the quarter, and had approximately $145.4 million of capacity remaining on our ATM Program as of March 31, 2024.
  • The company will host its fourth quarter earnings conference call and audio webcast on Thursday, May 2, 2024, at 11:00 a.m. Eastern Time.

BROADPEAK SA: América Móvil leads the way to High-Quality Video Streaming in LATAM with Broadpeak

Retrieved on: 
onsdag, april 10, 2024

Launching Broadpeak’s nanoCDN™ Multicast ABR Solution in the third country in LATAM, America Movil Increasing Bandwidth Savings While Maintaining Outstanding Quality for Live Video Streaming

Key Points: 
  • Launching Broadpeak’s nanoCDN™ Multicast ABR Solution in the third country in LATAM, America Movil Increasing Bandwidth Savings While Maintaining Outstanding Quality for Live Video Streaming
    CESSON-SEVIGNE, France — March 21, 2024 — Broadpeak®, a leading provider of content delivery network (CDN) and video streaming solutions for content providers and pay-TV operators worldwide, announced today that LATAM telecommunication group América Móvil is expanding its video streaming offerings with Broadpeak.
  • América Móvil has also deployed Broadpeak’s solutions, including multicast ABR, origin packager, CDN selector and CDN, in several LATAM countries.
  • “We’re excited to help such a major player as América Móvil fuel OTT multiscreen services.,” said Jacques Le Mancq, CEO at Broadpeak.
  • By adopting our multicast ABR solution, América Móvil is paving the way for more efficient video streaming in Latin America, cost-effectively handling traffic growth, and simplifying ABR live video delivery.”

ABR Dynamic Funds Welcomes Fourth Partner in Firm’s History

Retrieved on: 
tisdag, april 9, 2024

"Mehar's ascent within our organization exemplifies the values of pleasant persistence and determined excellence that we hold dear at ABR," says Taylor Lukof, CEO.

Key Points: 
  • "Mehar's ascent within our organization exemplifies the values of pleasant persistence and determined excellence that we hold dear at ABR," says Taylor Lukof, CEO.
  • Shah’s elevation to partnership at ABR coincides with her recent completion of the MBA program at NYU Stern School of Business while simultaneously balancing full-time employment at ABR.
  • My journey has been shaped by a lifelong commitment to learning, both from esteemed institutions, like NYU Stern, and from mentors within ABR.
  • ABR maintains its dedication to delivering innovative investment solutions, utilizing proprietary research and quantitative models to maximize risk-adjusted returns.

Arbor Realty Trust Declares Preferred Stock Dividends

Retrieved on: 
fredag, mars 29, 2024

UNIONDALE, N.Y., March 29, 2024 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of Directors has declared cash dividends on the Company's Series D, Series E, and Series F cumulative redeemable preferred stock of $0.3984375, $0.390625, and $0.390625 per share, respectively.

Key Points: 
  • UNIONDALE, N.Y., March 29, 2024 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of Directors has declared cash dividends on the Company's Series D, Series E, and Series F cumulative redeemable preferred stock of $0.3984375, $0.390625, and $0.390625 per share, respectively.
  • The Series D, E, and F preferred stock dividends reflect accrued dividends from January 30, 2024 through April 29, 2024.
  • The dividends are payable on April 30, 2024 to preferred stockholders of record on April 15, 2024.

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

Retrieved on: 
torsdag, mars 28, 2024

“This is an exciting and pivotal time for Centessa,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa.

Key Points: 
  • “This is an exciting and pivotal time for Centessa,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa.
  • Cash, Cash Equivalents and Short-term Investments: $256.5 million as of December 31, 2023, which includes approximately $6.2 million in net proceeds through ATM sales in the fourth quarter ended December 31, 2023.
  • General & Administrative Expenses: $12.3 million for the fourth quarter ended December 31, 2023, compared to $13.8 million the fourth quarter ended December 31, 2022, and $53.7 million for the full-year 2023 compared to $55.2 million for the full-year 2022.
  • Net Loss Attributable to Ordinary Shareholders: $36.8 million for the fourth quarter ended December 31, 2023, compared to $43.2 million for the fourth quarter ended December 31, 2022, and $151.1 million for the full-year 2023 compared to $216.2 million for the full-year 2022.